- Home
- NAGE vs INMD Comparison
NAGE vs INMD Comparison
Compare NAGE & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NAGE
- INMD
- Stock Information
- Founded
- NAGE 1999
- INMD 2008
- Country
- NAGE United States
- INMD Israel
- Employees
- NAGE N/A
- INMD N/A
- Industry
- NAGE Medicinal Chemicals and Botanical Products
- INMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- NAGE Health Care
- INMD Health Care
- Exchange
- NAGE Nasdaq
- INMD Nasdaq
- Market Cap
- NAGE 861.0M
- INMD 887.0M
- IPO Year
- NAGE N/A
- INMD 2019
- Fundamental
- Price
- NAGE $11.41
- INMD $14.71
- Analyst Decision
- NAGE Strong Buy
- INMD Hold
- Analyst Count
- NAGE 3
- INMD 6
- Target Price
- NAGE $16.67
- INMD $17.56
- AVG Volume (30 Days)
- NAGE 1.0M
- INMD 1.8M
- Earning Date
- NAGE 08-06-2025
- INMD 07-30-2025
- Dividend Yield
- NAGE N/A
- INMD N/A
- EPS Growth
- NAGE N/A
- INMD 8.69
- EPS
- NAGE 0.18
- INMD 2.29
- Revenue
- NAGE $107,925,000.00
- INMD $392,408,000.00
- Revenue This Year
- NAGE $26.44
- INMD $0.16
- Revenue Next Year
- NAGE $20.06
- INMD $4.84
- P/E Ratio
- NAGE $63.14
- INMD $6.42
- Revenue Growth
- NAGE 29.77
- INMD N/A
- 52 Week Low
- NAGE $2.52
- INMD $13.14
- 52 Week High
- NAGE $14.69
- INMD $19.85
- Technical
- Relative Strength Index (RSI)
- NAGE N/A
- INMD 52.26
- Support Level
- NAGE N/A
- INMD $14.95
- Resistance Level
- NAGE N/A
- INMD $15.63
- Average True Range (ATR)
- NAGE 0.00
- INMD 0.52
- MACD
- NAGE 0.00
- INMD 0.11
- Stochastic Oscillator
- NAGE 0.00
- INMD 63.05
About NAGE Niagen Bioscience Inc. Common Stock
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.
About INMD InMode Ltd.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF and Morpheus8. The majority of its revenue comes from the United States.